143 related articles for article (PubMed ID: 31888435)
1. PEIS: a novel approach of tumor purity estimation by identifying information sites through integrating signal based on DNA methylation data.
Wang S; Wang L; Zhang Y; Pang S; Wang X
BMC Bioinformatics; 2019 Dec; 20(Suppl 22):714. PubMed ID: 31888435
[TBL] [Abstract][Full Text] [Related]
2. PESM: A novel approach of tumor purity estimation based on sample specific methylation sites.
Pang S; Wang L; Wang S; Zhang Y; Wang X
J Bioinform Comput Biol; 2020 Oct; 18(5):2050027. PubMed ID: 32757807
[No Abstract] [Full Text] [Related]
3. Estimating and accounting for tumor purity in the analysis of DNA methylation data from cancer studies.
Zheng X; Zhang N; Wu HJ; Wu H
Genome Biol; 2017 Jan; 18(1):17. PubMed ID: 28122605
[TBL] [Abstract][Full Text] [Related]
4. Purity estimation from differentially methylated sites using Illumina Infinium methylation microarray data.
Azim R; Wang S; Zhou S; Zhong X
Cell Cycle; 2020 Aug; 19(16):2028-2039. PubMed ID: 32627651
[TBL] [Abstract][Full Text] [Related]
5. Universal informative CpG sites for inferring tumor purity from DNA methylation microarray data.
Dou H; Fang Y; Zheng X
J Bioinform Comput Biol; 2018 Jun; 16(3):1750030. PubMed ID: 29347875
[TBL] [Abstract][Full Text] [Related]
6. Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues.
Yan H; Guan Q; He J; Lin Y; Zhang J; Li H; Liu H; Gu Y; Guo Z; He F
J Transl Med; 2017 Feb; 15(1):26. PubMed ID: 28178989
[TBL] [Abstract][Full Text] [Related]
7. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z
Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885
[TBL] [Abstract][Full Text] [Related]
8. Tumor purity quantification by clonal DNA methylation signatures.
Benelli M; Romagnoli D; Demichelis F
Bioinformatics; 2018 May; 34(10):1642-1649. PubMed ID: 29325057
[TBL] [Abstract][Full Text] [Related]
9. RF_Purify: a novel tool for comprehensive analysis of tumor-purity in methylation array data based on random forest regression.
Johann PD; Jäger N; Pfister SM; Sill M
BMC Bioinformatics; 2019 Aug; 20(1):428. PubMed ID: 31419933
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
11. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
[TBL] [Abstract][Full Text] [Related]
12. Data-Driven-Based Approach to Identifying Differentially Methylated Regions Using Modified 1D Ising Model.
Zhang Y; Wang S; Wang X
Biomed Res Int; 2018; 2018():1070645. PubMed ID: 30581840
[TBL] [Abstract][Full Text] [Related]
13. Pan-Cancer Analysis Reveals Differential Susceptibility of Bidirectional Gene Promoters to DNA Methylation, Somatic Mutations, and Copy Number Alterations.
Thompson JA; Christensen BC; Marsit CJ
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30081598
[TBL] [Abstract][Full Text] [Related]
14. Identification of functionally methylated regions based on discriminant analysis through integrating methylation and gene expression data.
Zhang Y; Zhang J
Mol Biosyst; 2015 Jul; 11(7):1786-93. PubMed ID: 25865601
[TBL] [Abstract][Full Text] [Related]
15. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
[TBL] [Abstract][Full Text] [Related]
16. Copy number rather than epigenetic alterations are the major dictator of imprinted methylation in tumors.
Martin-Trujillo A; Vidal E; Monteagudo-Sánchez A; Sanchez-Delgado M; Moran S; Hernandez Mora JR; Heyn H; Guitart M; Esteller M; Monk D
Nat Commun; 2017 Sep; 8(1):467. PubMed ID: 28883545
[TBL] [Abstract][Full Text] [Related]
17. Intratumor heterogeneity index of breast carcinomas based on DNA methylation profiles.
Campoy EM; Branham MT; Mayorga LS; Roqué M
BMC Cancer; 2019 Apr; 19(1):328. PubMed ID: 30953488
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic and genetic burden measures are associated with tumor characteristics in invasive breast carcinoma.
O'Sullivan DE; Johnson KC; Skinner L; Koestler DC; Christensen BC
Epigenetics; 2016 May; 11(5):344-53. PubMed ID: 27070496
[TBL] [Abstract][Full Text] [Related]
19. An integrative study on the impact of highly differentially methylated genes on expression and cancer etiology.
Ozer B; Sezerman U
PLoS One; 2017; 12(2):e0171694. PubMed ID: 28178311
[TBL] [Abstract][Full Text] [Related]
20. Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
Wang H; Yan W; Zhang S; Gu Y; Wang Y; Wei Y; Liu H; Wang F; Wu Q; Zhang Y
Oncotarget; 2017 Jul; 8(30):48807-48819. PubMed ID: 28415743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
